In this video from the Canadian Pulmonary Fibrosis Foundation, shared in September 2014, a number of Canada’s leading pulmonary doctors and nurses, along with patients and caregivers, explain what it’s like to live with idiopathic pulmonary fibrosis. Discover why pulmonary fibrosis is so difficult to diagnose and treat. IPF…
Welcome to my column! As indicated by its title, “Younger than 30: Living with IPF,” I am a 28-year-old female recently diagnosed with idiopathic pulmonary fibrosis and trying to adjust to life with a fatal and debilitating disease as a young adult with much on the go. One of the biggest,…
Many different treatment options exist for patients with pulmonary fibrosis, but the treatment of last resort is lung transplant. Typically, lung transplants are suggested for patients whose lung disease is so progressed that they will not likely live another year or two. Lung transplants can dramatically improve the quality of life for people with acute…
Today, Oct. 17, is the 11th annual World Day for Organ Donation and Transplantation. While medical advances have resulted in increasing numbers of transplants performed each year, the availability of donor organs is still not enough to fulfill the urgent needs of all those awaiting a transplant. One reason for the limited availability is that…
Fall Tea Recipe With Antioxidants Fall is here. As we age, the changing season often comes with increased pain and inflammation. It seems unavoidable and managing it is a challenge. Homeopathic ways to relieve inflammation are worth a try. This turmeric tea recipe with ginger may have anti-inflammatory and antioxidant benefits.
This ea64Studios video follows the journey of 15 skateboarders on a mission: to skate 45 miles through Washington, D.C. to help raise awareness and funds for the Pulmonary Fibrosis Foundation. Read about the five main factors for living well with pulmonary fibrosis here. The documentary is dedicated…
A rare form of immune T-cells promotes chronic inflammation and pulmonary fibrosis, researchers at the Johns Hopkins University School of Medicine found. Their discovery, made in a mice model of the disease, may lead to a new therapeutic target for lung fibrosis. The research report, “Deletion of mTORC1 activity in CD4+ T cells…
In this Boehringer Ingelheim Idiopathic Pulmonary Fibrosis video shared in September 2014, Professor Ulrich Costabel from the Department of Pneumology and Allergology at the Ruhrlandklinik in Essen, Germany, discusses the causes of idiopathic pulmonary fibrosis. Find out more about personalized care for idiopathic pulmonary fibrosis patients here. Professor…
Pulmonary fibrosis is a rare lung condition where tissue in the lungs becomes scarred and stiff, which can lead to difficulties in breathing, a persistent cough, fatigue and weight loss. Often the cause is due to environmental factors or other health complications such as scleroderma or rheumatoid arthritis, but…
Statins provide beneficial effects, including decreased death risk, in a large and well-defined cohort of patients with idiopathic pulmonary fibrosis (IPF), according to an analysis of past studies. Findings were reported in the article “Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis,” recently published in…
Get regular updates to your inbox.
